Core Laboratories Inc. Director Resigns Over Strategic, Governance Dispute

What Happened Core Laboratories Inc. announced that director Kwaku Temeng informed the Board on August 19, 2026, that he intended to resign and confirmed that resignation in a letter dated August 25, 2026. His resignation is effective October 1, 2026. Mr. Temeng served as Chairman of the Nominating Committee and was a member of the Compensation Committee; the Board acknowledged his more than five years of service.

Key Details

• Resignation notice verbally given Aug. 19, 2026 and confirmed by letter Aug. 25, 2026; effective Oct. 1, 2026.
• Mr. Temeng served as Chair of the Nominating Committee and sat on the Compensation Committee.
• Cited reason: disagreement with the Board over the Company’s strategic direction and certain governance practices; Board identifies primary disagreement as succession planning and concerns about the Company’s research priorities.
• The resignation letter is filed as Exhibit 17.1 to the Form 8‑K; the Company offered Mr. Temeng an opportunity to state any disagreements with the filing.

Why It Matters A director departure, especially a committee chair, affects board composition and committee leadership and may prompt the company to name a replacement or reorganize committee roles before Oct. 1, 2026. The stated disagreements relate to succession planning and research priorities — topics material to governance and long‑term strategy that investors monitor for potential impact on management continuity and strategic execution. The filing contains only the resignation notice and the company’s description of the disagreement; no financial results or other corporate actions were reported in this 8‑K.